Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Asgard Therapeutics AB
AB
Active
Org 5591840136
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
9 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Asgard Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-21M
-42M
-64M
-85M
2020: 0M
0M
2020
2021: -1M
-1M
2021
2022: -27M (-2600% vs 2021)
-27M
-2600%
2022
2023: -28M (-4% vs 2022)
-28M
-4%
2023
2024: -68M (-143% vs 2023)
-68M
-143%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
0
0
433
Staff expenses
—
—
—
—
—
EBITDA
−67 840
−28 365
−27 191
−1 476
186
Depreciation & amort.
−399
−3
−1 472
−0
−0
EBIT
−68 239
−28 368
−28 663
−1 476
186
Net financials
2 789
198
−374
581
—
Profit before tax
−65 450
−28 170
−29 037
−860
151
Tax
−0
−0
−0
−0
−22
Net profit
−65 450
−28 170
−29 037
−860
129
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
104 918
11 421
35 680
20 619
1 436
Equity
97 085
4 847
33 017
18 554
621
Long-term debt
0
0
0
0
0
Short-term debt
7 833
6 574
2 663
2 064
781
Total debt
7 833
6 574
2 663
2 064
781
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
92,5 %
This company
38,2 %
Market median
This company
Market median
142% above market
2020
2024
Return on equity
−67,4 %
This company
18,4 %
Market median
This company
Market median
466% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
0,08×
This company
0,62×
Market median
This company
Market median
87% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Asgard Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
